ACIP approves most consequential changes to vaccine guidance this year

Senator Bill Cassidy, R-La., has publicly criticized the CDC's recent decision to roll back its recommendation for the hepatitis B vaccine for newborns, labeling it 'a mistake' that could jeopardize public health. This change follows a series of contentious discussions among CDC advisory panel members, reflecting a significant shift from previous guidelines.

The CDC advisory panel voted to limit hepatitis B vaccinations for newborns, a significant shift reflecting the Trump administration's controversial stance on vaccine guidelines. This decision follows a tumultuous meeting that raised concerns about misinformation and public health implications.

The CDC advisory panel has rolled back its recommendation for the hepatitis B vaccine for newborns, a significant shift from its previous guidelines. This decision follows a series of tumultuous meetings marked by misinformation and debate among panel members regarding the vaccine's necessity and safety.

Senator Bill Cassidy has expressed strong disapproval following a recent vote by a CDC panel that undermines a key vaccine norm he has supported, stating, 'This makes America sicker.' This decision reflects a significant shift in public health policy under Health Secretary Robert F. Kennedy Jr.

The CDC's vaccine advisory panel has reversed its long-standing recommendation for all newborns to receive the hepatitis B vaccine within 24 hours of birth after extensive debate. This decision marks a significant shift in public health policy regarding hepatitis B vaccination for infants.

A key vaccine panel at the Centers for Disease Control and Prevention (CDC) voted 8-3 to discontinue the recommendation that all newborns receive a first dose of the hepatitis B vaccine. This decision marks a significant shift in public health policy, overturning decades of guidance that aimed to prevent infections and liver cancer in infants.

The CDC advisory panel, influenced by Robert F. Kennedy Jr.'s vaccine skepticism, voted to delay the hepatitis B vaccination for most newborns, a decision that public health officials warn could lead to increased infections and lifelong liver diseases in infants.

The CDC's vaccine advisory panel has rolled back its long-standing recommendation for all newborns to receive the hepatitis B vaccine, marking a significant shift in public health policy. This decision follows a series of contentious meetings characterized by misinformation and debate among panel members.